These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15661802)

  • 1. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis.
    Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC
    Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
    Mi Z; Guo H; Wai PY; Gao C; Kuo PC
    Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A small interfering RNA targeting osteopontin as gastric cancer therapeutics.
    Gong M; Lu Z; Fang G; Bi J; Xue X
    Cancer Lett; 2008 Dec; 272(1):148-59. PubMed ID: 18694621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin inhibits macrophage nitric oxide synthesis to enhance tumor proliferation.
    Wai PY; Guo L; Gao C; Mi Z; Guo H; Kuo PC
    Surgery; 2006 Aug; 140(2):132-40. PubMed ID: 16904962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral-mediated siRNA targeted against osteopontin suppresses the growth and metastasis of gastric cancer cells.
    Wang ZM; Cui YH; Li W; Chen SY; Liu TS
    Oncol Rep; 2011 Apr; 25(4):997-1003. PubMed ID: 21286666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells.
    Liu H; Chen A; Guo F; Yuan L
    Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
    Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
    Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Knocking down osteopontin expression by specific siRNA reduces the in vitro invasiveness of human hepatocellular carcinoma cells].
    Zhu XQ; Ye QH; Lei KF; Chen J; Qin LX
    Zhonghua Zhong Liu Za Zhi; 2006 Jun; 28(6):404-7. PubMed ID: 17152482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inducible short-hairpin RNA vector against osteopontin reduces metastatic potential of human esophageal squamous cell carcinoma in vitro and in vivo.
    Ito T; Hashimoto Y; Tanaka E; Kan T; Tsunoda S; Sato F; Higashiyama M; Okumura T; Shimada Y
    Clin Cancer Res; 2006 Feb; 12(4):1308-16. PubMed ID: 16489088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
    Philip S; Bulbule A; Kundu GC
    Glycoconj J; 2004; 21(8-9):429-41. PubMed ID: 15750784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of osteopontin suppresses in vitro and in vivo angiogenesis in endometrial cancer.
    Du XL; Jiang T; Sheng XG; Gao R; Li QS
    Gynecol Oncol; 2009 Dec; 115(3):371-6. PubMed ID: 19783287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of osteopontin and related proteins in rat CC531 colorectal cancer cells.
    Georges R; Adwan H; Zhivkova M; Eyol E; Bergmann F; Berger MR
    Int J Oncol; 2010 Aug; 37(2):249-56. PubMed ID: 20596651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essential roles of tumor necrosis factor receptor p55 in liver metastasis of intrasplenic administration of colon 26 cells.
    Kitakata H; Nemoto-Sasaki Y; Takahashi Y; Kondo T; Mai M; Mukaida N
    Cancer Res; 2002 Nov; 62(22):6682-7. PubMed ID: 12438267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of progression and metastasis of established colon tumors in mice by intravenous delivery of short interfering RNA targeting KITENIN, a metastasis-enhancing protein.
    Lee JH; Cho ES; Kim MY; Seo YW; Kho DH; Chung IJ; Kook H; Kim NS; Ahn KY; Kim KK
    Cancer Res; 2005 Oct; 65(19):8993-9003. PubMed ID: 16204073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human macrophages promote the motility and invasiveness of osteopontin-knockdown tumor cells.
    Cheng J; Huo DH; Kuang DM; Yang J; Zheng L; Zhuang SM
    Cancer Res; 2007 Jun; 67(11):5141-7. PubMed ID: 17545592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
    Horak CE; Lee JH; Elkahloun AG; Boissan M; Dumont S; Maga TK; Arnaud-Dabernat S; Palmieri D; Stetler-Stevenson WG; Lacombe ML; Meltzer PS; Steeg PS
    Cancer Res; 2007 Aug; 67(15):7238-46. PubMed ID: 17671192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.